ERBB2 and breast cancer: Overall, the association of the SERS-Raman spectroscopy with the RNA interference technology provides valuable insights into the biology of HER2 + BC cells and, in particular, in a condition that mimics the effect of HER2-silencing targeted therapies [10, 12], a theme that is novel and not explored so far.